Use of genetically modified bacteria for drug delivery in humans: Revisiting the safety aspect

Abstract The use of live, genetically modified bacteria as delivery vehicles for biologics is of considerable interest scientifically and has attracted significant commercial investment. We have pioneered the use of the commensal gut bacterium Bacteroides ovatus for the oral delivery of therapeutics...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Udo Wegmann, Ana Lucia Carvalho, Martin Stocks, Simon R. Carding
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d47528c7b1b741b89f5e48981a26bc68
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!